BAKER BROS. ADVISORS LP 13D and 13G filings for Entrada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-26 4:54 pm Purchase | 2024-06-24 | 13D | Entrada Therapeutics, Inc. TRDA | BAKER BROS. ADVISORS LP | 4,865,819 13.200% | 161,400 (+3.43%) | Filing |
| 2021-12-16 5:23 pm Unchanged | 2021-12-14 | 13D | Entrada Therapeutics, Inc. TRDA | BAKER BROS. ADVISORS LP | 4,704,419 15.100% | 0 (Unchanged) | Filing |
| 2021-11-10 4:50 pm Purchase | 2021-11-02 | 13G | Entrada Therapeutics, Inc. TRDA | BAKER BROS. ADVISORS LP | 4,704,419 15.100% | 4,704,419 (New Position) | Filing |